Cargando…
Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, “Naked” Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells
Despite the use of sorafenib as one of the most effective drugs for the treatment of liver cancer, its significant limitations remain—poor solubility, the need to use high doses with the ensuing complications on healthy tissues and organs, and the formation of cell resistance to the drug. At the sam...
Autores principales: | Varlamova, Elena G., Goltyaev, Mikhail V., Simakin, Aleksander V., Gudkov, Sergey V., Turovsky, Egor A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223423/ https://www.ncbi.nlm.nih.gov/pubmed/35743086 http://dx.doi.org/10.3390/ijms23126641 |
Ejemplares similares
-
Mechanisms of the Cytotoxic Effect of Selenium Nanoparticles in Different Human Cancer Cell Lines
por: Varlamova, Elena G., et al.
Publicado: (2021) -
Ca(2+)-Dependent Effects of the Selenium-Sorafenib Nanocomplex on Glioblastoma Cells and Astrocytes of the Cerebral Cortex: Anticancer Agent and Cytoprotector
por: Varlamova, Elena G., et al.
Publicado: (2023) -
Size-Dependent Cytoprotective Effects of Selenium Nanoparticles during Oxygen-Glucose Deprivation in Brain Cortical Cells
por: Varlamova, Elena G., et al.
Publicado: (2022) -
Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
por: Varlamova, Elena G., et al.
Publicado: (2021) -
The Role of Selenium Nanoparticles in the Treatment of Liver Pathologies of Various Natures
por: Goltyaev, Michael V., et al.
Publicado: (2023)